Blood and urine tests to predict kidney failure in cirrhosis
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study checks new blood and urine tests to predict who with advanced liver scarring (cirrhosis) will develop hepatorenal syndrome, a serious kidney problem. The results may help doctors spot risk earlier, especially for people being referred for a liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cirrhosis labeled Child-Pugh B or C
- You are being referred for a liver transplant
- You are willing to sign informed consent to join the study
- You do not have other known kidney diseases (besides the liver-related problem)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at kidney tissue from patients having a liver transplant to understand and improve treatment for a kidney problem called hepatorenal syndrome. It may help doctors find better ways to protect kidney function after transplant.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This study looks at how liver cirrhosis affects kidney health. If you have cirrhosis, researchers will check your kidney function and track changes over a short time to learn more about kidney problems in people with cirrhosis.
This study aims to create a formula to predict which patients with liver cirrhosis and fluid in the belly might develop kidney issues. It uses routine lab tests to help doctors identify risks early and plan better care.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This trial studies whether special non-invasive ultrasound scans can help predict outcomes in people who have both liver-related high blood pressure in the veins (portal hypertension) and kidney failure. It may help doctors choose better monitoring and treatment for this specific combination of problems.
Hear when a new Hepatorenal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.